OneOme Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $100K

  • Investors
  • 3

OneOme General Information

Description

Developer of a pharmacogenomic and analytical platform designed to help doctors select medications to improve outcomes and reduce adverse drug reactions. The company offers individual patient pharmacogenomic analysis and population management, enabling healthcare providers to make more informed treatment decisions.

Contact Information

Website
www.oneome.com
Formerly Known As
PGx Newco
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 807 Broadway Street North East
  • Suite 100
  • Minneapolis, MN 55413
  • United States
+1 (844) 000-0000
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Decision/Risk Analysis
Laboratory Services (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 807 Broadway Street North East
  • Suite 100
  • Minneapolis, MN 55413
  • United States
+1 (844) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OneOme Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 14-Jun-2017 $100K 00.000 Completed Generating Revenue
2. Seed Round 05-Oct-2016 00.000 00.000 Completed Generating Revenue
1. Spin-Off 01-Jan-2013 Completed Generating Revenue
To view OneOme’s complete valuation and funding history, request access »

OneOme Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pharmacogenomic and analytical platform designed to help doctors select medications to improve outcomes a
Biotechnology
Minneapolis, MN
49 As of 2024
00.000
0000000000 0 00.000

000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
00000 0000000000 000
King of Prussia, PA
00 As of 0000
000.00
00000 0000-00-00
00000000000 000.00

00000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000000 000000
San Mateo, CA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OneOme Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomind Venture Capital-Backed King of Prussia, PA 00 000.00 00000000000 000.00
Helix Venture Capital-Backed San Mateo, CA 000 00000 00000000000 00000
OmeCare Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
YouScript Formerly VC-backed Seattle, WA 00 00.00 000000&0
ActX Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
You’re viewing 5 of 12 competitors. Get the full list »

OneOme Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

OneOme Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230181122-A1 Stratification engine for pharmacogenomic testing Pending 10-Dec-2021 0000000000
US-20180135122-A1 Systems and methods for genotype-derived drug recommendations Inactive 11-Nov-2016 0000000000

OneOme Executive Team (14)

Name Title Board Seat
Patrick McIntyre Chief Executive Officer & Board Member
Jamie Dupris Senior Finance Director
James Kelley Ph.D Chief Medical Officer
You’re viewing 3 of 14 executive team members. Get the full list »

OneOme Board Members (8)

Name Representing Role Since
Jeremy Friese MD Self Board Member 000 0000
Patrick McIntyre OneOme Chief Executive Officer & Board Member 000 0000
You’re viewing 2 of 8 board members. Get the full list »

OneOme Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OneOme Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Labcorp Venture Fund Corporate Venture Capital 000 0000 000000 0
Invenshure Accelerator/Incubator Minority 000 0000 000000 0
Mayo Clinic Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view OneOme’s complete investors history, request access »

Ready to get started?

Request a free trial

OneOme FAQs

  • When was OneOme founded?

    OneOme was founded in 2013.

  • Who is the CEO of OneOme?

    Patrick McIntyre is the CEO of OneOme.

  • Where is OneOme headquartered?

    OneOme is headquartered in Minneapolis, MN.

  • What is the size of OneOme?

    OneOme has 49 total employees.

  • What industry is OneOme in?

    OneOme’s primary industry is Biotechnology.

  • Is OneOme a private or public company?

    OneOme is a Private company.

  • What is OneOme’s current revenue?

    The current revenue for OneOme is 00000.

  • How much funding has OneOme raised over time?

    OneOme has raised $6.39M.

  • Who are OneOme’s investors?

    Labcorp Venture Fund, Invenshure, and Mayo Clinic Ventures have invested in OneOme.

  • Who are OneOme’s competitors?

    Genomind, Helix, OmeCare, YouScript, and ActX are some of the 12 competitors of OneOme.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »